Parexel

Parexel launches Parexel MyTrials fully-integrated eClinical platform

Monday, June 18, 2012 10:14 AM

Parexel International, a global biopharmaceutical services provider based in Boston, Mass., has launched the Parexel MyTrials platform, a fully-integrated eClinical solution that simplifies the clinical trial process.

More... »

Parexel releases quarterly financial results

Wednesday, May 2, 2012 09:56 AM

Global CRO Parexel International has released its financial results for the third quarter ended March 31, 2012.

More... »

Survey reveals top concerns in biopharmas achieving commercial success

Friday, March 16, 2012 01:53 PM

Parexel Consulting, a global consultancy service and subsidiary of Parexel International, has released results from a survey polling biopharmaceutical industry professionals, finding that 75% feel the top concern about achieving commercial success is establishing a product price that is reimbursed and accepted by the market.

More... »

Survey shows significant adoption of web-based RTSM systems by clinical sites

Friday, March 16, 2012 12:41 PM

Perceptive Informatics, an eClinical solutions provider and a subsidiary of Parexel International, has reported results of its Randomization and Trial Supply Management (RTSM) survey, which tracked the evolving use of interactive voice and web response technologies by investigative sites worldwide.

More... »

Parexel expands global clinical logistics capabilities

Wednesday, February 8, 2012 12:45 PM

Global CRO Parexel International is expanding its global clinical logistics services.

More... »

Parexel and ASAN accelerate Korea-based drug development

Wednesday, February 1, 2012 03:33 PM

CRO Parexel International has joined with ASAN Medical Center (AMC), based in Seoul, Korea, to offer clinical trial sponsors based regionally and internationally access to clinical trial services throughout Asia, with a focus on early phase development.

More... »

Parexel posts revenue increase in second quarter

Tuesday, January 31, 2012 02:23 PM

Boston-based CRO Parexel International posted a 9.5% increase in consolidated service revenue for the second quarter ended Dec. 31, 2011, to $333.2 million, from a year ago.

More... »

Parexel forms early-phase alliance with U.K.’s UH Bristol

Tuesday, January 24, 2012 10:46 AM

Parexel International, a Boston-based global biopharmaceutical services provider, has established an alliance with University Hospitals Bristol National Health Service (NHS) Foundation Trust (UH Bristol), one of the largest specialist teaching and research hospital trusts in the United Kingdom.

More... »

Perceptive Informatics garners top ratings

Friday, January 20, 2012 03:06 PM

Perceptive Informatics, an eClinical solutions provider and a subsidiary of Parexel International, received top marks for its medical imaging services in an independent survey on the medical imaging market conducted by Blue Pyramid Consulting.

More... »

Dr. Andrea Zobel joins Marken

Friday, January 13, 2012 12:07 PM

Marken has named Dr. Andrea Zobel new senior director of clinical trial distribution operations.

More... »